Skip to main content
. 2019 Jan-Feb;29(1):15–21. doi: 10.4103/ijn.IJN_437_17

Table 6.

Summary of studies comparing patients with dengue with and without AKI

Author’s name Study population Demographics (n, age, gender) Severity of dengue AKI definition Incidence of AKI Longer hospitalization (AKI vs non-AKI) Mortality (AKI vs. non AKI)
Lee et al.[7] (retrospective) Patients of all age groups 304, 139 males, age range 19-88 years DHF SCr >2 mg/dL 3.3% NR 60% vs. 0%
Lee et al.[9] (retrospective) Patients of all age groups 307, 139 males, age range 37-74 years DHF SCr >2 mg/dL 3.9% NR NR
Mehra et al.[5] (retrospective) Patients of all age groups 223, 130 males, mean age 26.2±18.2 years DVI AKIN 10.8% NR Overall: 9%*
AKIN-I: 5.4%
AKIN-II: 3.1%
AKIN-III: 2.2%
Khalil et al.[5] (retrospective) Patients of all age groups 532, 377 males, mean age 35.2±14.7 years DVI AKIN 13.3% 59.2% vs. 22.6% 11.3% vs. 0%
AKIN-I: 64.8%
AKIN-II: 18.3%
AKIN-III: 16.9%
Mallhi et al.[8] (retrospective) Age group >12 years 667, 378 male, 289 female DVI AKIN 14.2% 65.3% vs. 48.3% 8.4% vs. 0%
Our study (retrospective) Patients of age groups >14 years 620, 353 males, 267 female DVI AKIN 16.36% 55.55% vs. 50.9% 15.61% vs. 0%

n: Number of patients enrolled in study, DVI: Dengue viral infection including all severities (DF, DHF, DSS), AKI: Acute kidney injury, AKIN: Acute Kidney Injury Network classification, AKIN-I, II, III, three severity stages of AKIN network classification, DHF: Dengue hemorrhagic fever, DSS: Dengue shock syndrome, SCr: Serum creatinine (mg/dL), NR: Not reported